Clinical Trial

Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan

Name: Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan — clinical trial record (NCT07383025)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the real-world effectiveness and safety of mavacamten in patients with obstructive hypertrophic cardiomyopathy (HCM) receiving mavacamten in Japan

Trial Details

NCT Number	NCT07383025
Lead Sponsor	Bristol-Myers Squibb
Conditions	Obstructive Hypertrophic Cardiomyopathy (oHCM)
Enrollment	200 participants
Start Date	2025-05-21
Primary Completion	2029-11-30 (estimated)
Study Completion	2029-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-03